Literature DB >> 22170465

Age at menarche is associated with prediabetes and diabetes in women (aged 32-81 years) from the general population: the KORA F4 Study.

D Stöckl1, A Döring, A Peters, B Thorand, M Heier, C Huth, H Stöckl, W Rathmann, B Kowall, C Meisinger.   

Abstract

AIMS/HYPOTHESIS: The aim of this study was to examine the association between age at menarche and prediabetes as well as diabetes, considering confounding factors and the possible mediating role of adult obesity.
METHODS: This cross-sectional study analysed data on 1,503 women aged 32-81 years from the German population-based KORA (Cooperative Health Research in the Region of Augsburg, South Germany) F4 Study (2006-2008). Data were collected by standardised interviews, physical examinations, and whole blood and serum measurements, including administration of an OGTT in non-diabetic participants.
RESULTS: Of the 1,503 women, 226 showed a prediabetic state (impaired fasting glucose and/or impaired glucose tolerance) and 140 persons had diabetes (45 participants with previously undiagnosed diabetes and 95 with known diabetes). In Poisson regression analysis, age at menarche was significantly inversely associated with prediabetes or diabetes after adjustment for year of birth (RR 0.88; 95% CI 0.82, 0.94, p < 0.0001 per additional year of menarche) and after additional adjustment for a number of confounding factors (RR 0.88; 95% CI 0.83, 0.94, p = 0.0001). Further adjustment for current BMI slightly attenuated the association with prediabetes or diabetes (RR 0.89; 95% CI 0.83, 0.95, p = 0.0009), but the association remained clearly significant. CONCLUSIONS/
INTERPRETATION: Age at menarche seems to be inversely associated with prediabetes and diabetes independent of confounding factors including current BMI. Women at risk for diabetes might be identified by a history of young age at menarche.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22170465     DOI: 10.1007/s00125-011-2410-3

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  36 in total

1.  Reliability of data on medical conditions, menstrual and reproductive history provided by hospital controls.

Authors:  C Bosetti; A Tavani; E Negri; D Trichopoulos; C La Vecchia
Journal:  J Clin Epidemiol       Date:  2001-09       Impact factor: 6.437

2.  Type 2 diabetes risk alleles near ADCY5, CDKAL1 and HHEX-IDE are associated with reduced birthweight.

Authors:  E A Andersson; K Pilgaard; C Pisinger; M N Harder; N Grarup; K Faerch; P Poulsen; D R Witte; T Jørgensen; A Vaag; T Hansen; O Pedersen
Journal:  Diabetologia       Date:  2010-05-20       Impact factor: 10.122

3.  Age at menarche, total mortality and mortality from ischaemic heart disease and stroke: the Adventist Health Study, 1976-88.

Authors:  B K Jacobsen; K Oda; S F Knutsen; G E Fraser
Journal:  Int J Epidemiol       Date:  2009-02       Impact factor: 7.196

4.  Age at menarche and adult BMI in the Aberdeen children of the 1950s cohort study.

Authors:  Mary B Pierce; David A Leon
Journal:  Am J Clin Nutr       Date:  2005-10       Impact factor: 7.045

5.  Age at menarche, abnormal glucose tolerance and type 2 diabetes mellitus: The Rancho Bernardo Study.

Authors:  N Saquib; D Kritz-Silverstein; E Barrett-Connor
Journal:  Climacteric       Date:  2005-03       Impact factor: 3.005

6.  Age at menarche and risk of type 2 diabetes: results from 2 large prospective cohort studies.

Authors:  Chunyan He; Cuilin Zhang; David J Hunter; Susan E Hankinson; Germaine M Buck Louis; Mary L Hediger; Frank B Hu
Journal:  Am J Epidemiol       Date:  2009-12-21       Impact factor: 4.897

7.  Association of low age at menarche with increased all-cause mortality: a 37-year follow-up of 61,319 Norwegian women.

Authors:  Bjarne K Jacobsen; Ivar Heuch; Gunnar Kvåle
Journal:  Am J Epidemiol       Date:  2007-09-17       Impact factor: 4.897

Review 8.  Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis.

Authors:  Eric L Ding; Yiqing Song; Vasanti S Malik; Simin Liu
Journal:  JAMA       Date:  2006-03-15       Impact factor: 56.272

9.  Early age at menarche associated with cardiovascular disease and mortality.

Authors:  Rajalakshmi Lakshman; Nita G Forouhi; Stephen J Sharp; Robert Luben; Sheila A Bingham; Kay-Tee Khaw; Nicholas J Wareham; Ken K Ong
Journal:  J Clin Endocrinol Metab       Date:  2009-10-30       Impact factor: 5.958

10.  Age at menarche and its association with the metabolic syndrome and its components: results from the KORA F4 study.

Authors:  Doris Stöckl; Christa Meisinger; Annette Peters; Barbara Thorand; Cornelia Huth; Margit Heier; Wolfgang Rathmann; Bernd Kowall; Heidi Stöckl; Angela Döring
Journal:  PLoS One       Date:  2011-10-18       Impact factor: 3.240

View more
  31 in total

1.  Association between Age at Menarche and Cardiovascular Disease Risk Factors in China: A Large Population-Based Investigation.

Authors:  Yansong Zheng; Guilan Zhang; Zhilai Chen; Qiang Zeng
Journal:  Cardiorenal Med       Date:  2016-05-26       Impact factor: 2.041

2.  Age at menarche and risk of type 2 diabetes among African-American and white women in the Atherosclerosis Risk in Communities (ARIC) study.

Authors:  J G Dreyfus; P L Lutsey; R Huxley; J S Pankow; E Selvin; L Fernández-Rhodes; N Franceschini; E W Demerath
Journal:  Diabetologia       Date:  2012-07-04       Impact factor: 10.122

3.  Age at menarche and the risk of gestational diabetes mellitus: a systematic review and meta-analysis.

Authors:  Xiaoting Sun; Lili Yang; Jiexue Pan; Haiyan Yang; Yanting Wu; Zimiao Chen; Xia Chen; Liangshan Mu
Journal:  Endocrine       Date:  2018-03-20       Impact factor: 3.633

4.  Age at Menarche and Risk of Gestational Diabetes Mellitus: A Prospective Cohort Study Among 27,482 Women.

Authors:  Liwei Chen; Shanshan Li; Chunyan He; Yeyi Zhu; Germaine M Buck Louis; Edwina Yeung; Frank B Hu; Cuilin Zhang
Journal:  Diabetes Care       Date:  2016-01-26       Impact factor: 19.112

5.  Association of age at menarche with metabolic syndrome and its components in rural Bangladeshi women.

Authors:  Shamima Akter; Subrina Jesmin; Mazedul Islam; Sayeeda Nusrat Sultana; Osamu Okazaki; Michiaki Hiroe; Masao Moroi; Taro Mizutani
Journal:  Nutr Metab (Lond)       Date:  2012-11-09       Impact factor: 4.169

6.  Age at Menarche and Cardiometabolic Risk in Adulthood: The Coronary Artery Risk Development in Young Adults Study.

Authors:  Jill Dreyfus; David R Jacobs; Noel Mueller; Pamela J Schreiner; Antoinette Moran; Mercedes R Carnethon; Ellen W Demerath
Journal:  J Pediatr       Date:  2015-05-09       Impact factor: 6.314

7.  Reproductive history and risk of type 2 diabetes mellitus in postmenopausal women: findings from the Women's Health Initiative.

Authors:  Erin S LeBlanc; Kristopher Kapphahn; Haley Hedlin; Manisha Desai; Nisha I Parikh; Simin Liu; Donna R Parker; Matthew Anderson; Vanita Aroda; Shannon Sullivan; Nancy F Woods; Molly E Waring; Cora E Lewis; Marcia Stefanick
Journal:  Menopause       Date:  2017-01       Impact factor: 2.953

8.  Faster life history strategy manifests itself by lower age at menarche, higher sexual desire, and earlier reproduction in people with worse health.

Authors:  Kateřina Sýkorová; Jaroslav Flegr
Journal:  Sci Rep       Date:  2021-05-27       Impact factor: 4.379

9.  Age at menarche and its relationship to body mass index among adolescent girls in Kuwait.

Authors:  Nora Al-Awadhi; Nouf Al-Kandari; Teebah Al-Hasan; Daliah Almurjan; Salhah Ali; Abdullah Al-Taiar
Journal:  BMC Public Health       Date:  2013-01-12       Impact factor: 3.295

10.  Association of adiposity genetic variants with menarche timing in 92,105 women of European descent.

Authors:  Lindsay Fernández-Rhodes; Ellen W Demerath; Diana L Cousminer; Ran Tao; Jill G Dreyfus; Tõnu Esko; Albert V Smith; Vilmundur Gudnason; Tamara B Harris; Lenore Launer; Patrick F McArdle; Laura M Yerges-Armstrong; Cathy E Elks; David P Strachan; Zoltán Kutalik; Peter Vollenweider; Bjarke Feenstra; Heather A Boyd; Andres Metspalu; Evelin Mihailov; Linda Broer; M Carola Zillikens; Ben Oostra; Cornelia M van Duijn; Kathryn L Lunetta; John R B Perry; Anna Murray; Daniel L Koller; Dongbing Lai; Tanguy Corre; Daniela Toniolo; Eva Albrecht; Doris Stöckl; Harald Grallert; Christian Gieger; Caroline Hayward; Ozren Polasek; Igor Rudan; James F Wilson; Chunyan He; Peter Kraft; Frank B Hu; David J Hunter; Jouke-Jan Hottenga; Gonneke Willemsen; Dorret I Boomsma; Enda M Byrne; Nicholas G Martin; Grant W Montgomery; Nicole M Warrington; Craig E Pennell; Lisette Stolk; Jenny A Visser; Albert Hofman; André G Uitterlinden; Fernando Rivadeneira; Peng Lin; Sherri L Fisher; Laura J Bierut; Laura Crisponi; Eleonora Porcu; Massimo Mangino; Guangju Zhai; Tim D Spector; Julie E Buring; Lynda M Rose; Paul M Ridker; Charles Poole; Joel N Hirschhorn; Joanne M Murabito; Daniel I Chasman; Elisabeth Widen; Kari E North; Ken K Ong; Nora Franceschini
Journal:  Am J Epidemiol       Date:  2013-04-04       Impact factor: 4.897

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.